Twomey Christopher J
TWOMEY CHRISTOPHER J, DIR, reported a transaction classified as exercise at TANDEM DIABETES CARE INC involving 1700.000000 shares for an estimated $32300.00. Reported holdings after the transaction were 26134.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Oct 27, 2026
- Filing date
- Oct 29, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TNDM price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001438133-26-000136 Common Stock
- Transaction date
- Oct 27, 2026 Filed Oct 29, 2026, 08:06 PM · 2d delay
- Shares
- 1,700 sh $19.00 per share
- Estimated value
- $32.3k Computed from shares × price
- Holdings after
- 26,134 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
Represents shares of common stock received upon exercise of a stock option award.
- F2
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2026.
- F3
The securities are directly owned by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over
these securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such
securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.
- F4
The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.
- F5
Awarded on November 15, 2016 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto.
- F6
Such options became exercisable in 12 equal monthly installments beginning on December 15, 2016.
- F7
Such options expire on November 15, 2026.
0 other transactions
0 recent txs